FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311702743> ?p ?o ?g. }

• W4311702743 abstract "Non-segmental vitiligo (NSV) is an autoimmune skin disorder that is difficult to determine disease activity/severity and thus to treat. Alarmins have emerged as promising biomarkers in various diseases, so further confirmation of their potential roles in NSV would be of considerable value. With the present work, we aimed to determine the serum levels of alarmins in patients with NSV, correlate these alarmins with disease activity and severity, and analyze the predictive value of the combination of these markers.104 NSV patients and 56 healthy controls were enrolled at the Xijing Hospital of Fourth Military Medical University between September 1, 2018, and June 30, 2019. The serum levels of alarmins (including IL-33, IL-1α, S100A9, S100A12, S100B, and HMGB1) were measured with enzyme-linked immunosorbent assays. The predictive performance of these biomarkers was evaluated with the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and other representative statistics.A total of 104 patients with NSV (mean [SD] age, 34.2 [13.0] years; 62 [59.6%] male) and 56 healthy controls (mean [SD] age, 34.8 [13.5] years; 34 [60.7%] male) were enrolled. For vitiligo diagnosis, S100B had the highest sensitivity (92.31%), whereas HMGB1 had the highest specificity (85.71%); the combination of IL-1α, S100B, S100A9, and HMGB1 increased the AUC value to 0.925, with a sensitivity of 87.50% and a specificity of 85.71%. Multivariate logistic regression analysis showed S100B (OR, 1.019; 95% CI, 1.002-1.038; P =0.03), S100A9 (OR, 1.002; 95% CI, 1.001-1.003; P<0.001), and HMGB1 (OR, 1.915; 95% CI, 1.186-3.091; P =0.008) were significantly associated with vitiligo activity. S100A9 had the highest accuracy in discriminating patients at the active stage from the stable stage, with an AUC value of 0.827. The combination of these alarmins had an AUC value of 0.860 to assess disease activity, with a sensitivity of 90.00% and a specificity of 72.97%. Furthermore, S100B (r=0.61, P <0.001), S100A9 (r=0.33, P <0.001), and HMGB1 (r = 0.51, P <0.001) levels were positively correlated with the affected body surface area (BSA) in NSV patients.Serum S100B, S100A9, and HMGB1 might be biomarkers for diagnosing and assessing the activity/severity of NSV, either used alone or in combination." @default.
• W4311702743 created "2022-12-28" @default.
• W4311702743 creator A5003030386 @default.
• W4311702743 creator A5023006263 @default.
• W4311702743 creator A5034959305 @default.
• W4311702743 creator A5040238984 @default.
• W4311702743 creator A5045867877 @default.
• W4311702743 creator A5047214344 @default.
• W4311702743 creator A5059374757 @default.
• W4311702743 date "2022-12-07" @default.
• W4311702743 modified "2023-09-28" @default.
• W4311702743 title "Circulatory levels of alarmins in patients with non-segmental vitiligo: Potential biomarkers for disease diagnosis and activity/severity assessment" @default.
• W4311702743 cites W1981424925 @default.
• W4311702743 cites W1984358129 @default.
• W4311702743 cites W2000551327 @default.
• W4311702743 cites W2008794259 @default.
• W4311702743 cites W2022539276 @default.
• W4311702743 cites W2030646916 @default.
• W4311702743 cites W2042247594 @default.
• W4311702743 cites W2050805027 @default.
• W4311702743 cites W2059498235 @default.
• W4311702743 cites W2076961991 @default.
• W4311702743 cites W2150256078 @default.
• W4311702743 cites W2170489756 @default.
• W4311702743 cites W2328549172 @default.
• W4311702743 cites W2342342930 @default.
• W4311702743 cites W2463803272 @default.
• W4311702743 cites W2516058974 @default.
• W4311702743 cites W2587971787 @default.
• W4311702743 cites W2592566687 @default.
• W4311702743 cites W2626458389 @default.
• W4311702743 cites W2761905894 @default.
• W4311702743 cites W2795539529 @default.
• W4311702743 cites W2807960214 @default.
• W4311702743 cites W2912555011 @default.
• W4311702743 cites W2938390710 @default.
• W4311702743 cites W2980325783 @default.
• W4311702743 cites W3095612328 @default.
• W4311702743 cites W3135203598 @default.
• W4311702743 cites W3186240419 @default.
• W4311702743 cites W4200255435 @default.
• W4311702743 cites W4211244313 @default.
• W4311702743 cites W4285680006 @default.
• W4311702743 cites W4287009798 @default.
• W4311702743 cites W89672205 @default.
• W4311702743 doi "https://doi.org/10.3389/fimmu.2022.1069196" @default.
• W4311702743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36569840" @default.
• W4311702743 hasPublicationYear "2022" @default.
• W4311702743 type Work @default.
• W4311702743 citedByCount "0" @default.
• W4311702743 crossrefType "journal-article" @default.
• W4311702743 hasAuthorship W4311702743A5003030386 @default.
• W4311702743 hasAuthorship W4311702743A5023006263 @default.
• W4311702743 hasAuthorship W4311702743A5034959305 @default.
• W4311702743 hasAuthorship W4311702743A5040238984 @default.
• W4311702743 hasAuthorship W4311702743A5045867877 @default.
• W4311702743 hasAuthorship W4311702743A5047214344 @default.
• W4311702743 hasAuthorship W4311702743A5059374757 @default.
• W4311702743 hasBestOaLocation W43117027431 @default.
• W4311702743 hasConcept C112705442 @default.
• W4311702743 hasConcept C126322002 @default.
• W4311702743 hasConcept C151956035 @default.
• W4311702743 hasConcept C185592680 @default.
• W4311702743 hasConcept C203014093 @default.
• W4311702743 hasConcept C2779134260 @default.
• W4311702743 hasConcept C2779980618 @default.
• W4311702743 hasConcept C2781197716 @default.
• W4311702743 hasConcept C3020225094 @default.
• W4311702743 hasConcept C55493867 @default.
• W4311702743 hasConcept C58471807 @default.
• W4311702743 hasConcept C71924100 @default.
• W4311702743 hasConcept C76318530 @default.
• W4311702743 hasConcept C90924648 @default.
• W4311702743 hasConceptScore W4311702743C112705442 @default.
• W4311702743 hasConceptScore W4311702743C126322002 @default.
• W4311702743 hasConceptScore W4311702743C151956035 @default.
• W4311702743 hasConceptScore W4311702743C185592680 @default.
• W4311702743 hasConceptScore W4311702743C203014093 @default.
• W4311702743 hasConceptScore W4311702743C2779134260 @default.
• W4311702743 hasConceptScore W4311702743C2779980618 @default.
• W4311702743 hasConceptScore W4311702743C2781197716 @default.
• W4311702743 hasConceptScore W4311702743C3020225094 @default.
• W4311702743 hasConceptScore W4311702743C55493867 @default.
• W4311702743 hasConceptScore W4311702743C58471807 @default.
• W4311702743 hasConceptScore W4311702743C71924100 @default.
• W4311702743 hasConceptScore W4311702743C76318530 @default.
• W4311702743 hasConceptScore W4311702743C90924648 @default.
• W4311702743 hasFunder F4320321001 @default.
• W4311702743 hasLocation W43117027431 @default.
• W4311702743 hasLocation W43117027432 @default.
• W4311702743 hasLocation W43117027433 @default.
• W4311702743 hasLocation W43117027434 @default.
• W4311702743 hasOpenAccess W4311702743 @default.
• W4311702743 hasPrimaryLocation W43117027431 @default.
• W4311702743 hasRelatedWork W2122443163 @default.
• W4311702743 hasRelatedWork W2154039449 @default.
• W4311702743 hasRelatedWork W2386767720 @default.
• W4311702743 hasRelatedWork W2568698376 @default.
• W4311702743 hasRelatedWork W2905398573 @default.
• W4311702743 hasRelatedWork W3012891291 @default.

• next